IMPORTANCE Clinically isolated syndrome (CIS) describes a first clinical incident suggestive of multiple sclerosis (MS). Identifying patients with CIS who have a high risk of future disease activity and subsequent MS diagnosis is crucial for patient monitoring and the initiation of disease-modifying therapy.
M ultiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system (CNS) and an important cause of sustained disability in young adults. 1 Early disease-modifying therapy of MS can improve long-term outcome and reduce the accrual of irreversible disability, which makes timely and accurate diagnosis of MS imperative. 2, 3 The cause of MS is unknown, 4 and in absence of a specific pathologic correlate, current diagnostic criteria rely on clinical presentation and typical MS lesions obtained in magnetic resonance imaging (MRI). 5 Either way, dissemination of clinical or radiographic disease activity needs to be proven both in space and time.
The term clinically isolated syndrome (CIS) was coined to describe the monophasic attack that heralds the onset of MS in most of patients. 6 In 11% to 34% of patients with CIS, a diagnosis of MS can already be established after this first event using MRI. 5 In the remainder, MRI is not indicative of dissemination in both space and time, typically missing the time criterion. 7, 8 In these patients, a diagnosis of MS cannot yet be established, but more than 80% develop new lesions and more than 60% experience a second clinical attack within 20 years and are then diagnosed with MS. 9 Of the total population of patients with CIS, 15% to 20% never have a second clinical attack. 10 Known risk factors of future disease activity and a subsequent MS diagnosis in CIS include young age, intrathecal immunoglobulin synthesis, and the presence of brain lesions, 11 particularly in the infratentorial region.
6,12
Optical coherence tomography (OCT) is a noninvasive tool used to quantify retinal neuroaxonal damage in MS and other neurologic diseases. [13] [14] [15] [16] Peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell layer thinning occurs in patients with MS after optic neuritis (ON) 17,18 but also independently of ON. 19, 20 In a retrospective study, pRNFL was associated with disability worsening in MS. 21 Another study suggests that inner nuclear layer thickness (INL) may be useful for monitoring disease-modifying therapy in the following 12 months.
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In this study, we investigate the value of retinal ganglion cell and inner plexiform layer thickness (GCIP) as a novel parameter of neuronal retinal damage to assess subsequent disease activity in CIS.
Methods

Study Design
Patients were prospectively included from 2 ongoing observational cohort studies at the university hospitals in Berlin and Munich (Cohort Study of Clinically Isolated Syndrome and Early Multiple Sclerosis [CIS-COHORT; ClinicalTrials.gov Identifier: NCT01371071] in Berlin and TUM-MS cohort in Munich) of patients with CIS and early MS who were recruited between January 2011 and September 2015 (in Berlin, from January 2011 to August 2014; in Munich, from August 2013 to September 2015) and followed up until May 2017. Inclusion criteria were (1) an age between 18 and 60 years; (2) a first clinical event suggestive of MS in the previous 365 days after extensive diagnostic workup for alternative causes, and (3) an observation period of at least 365 days after study inclusion.
Details on data collection and data screening can be found in the eMethods in the Supplement. The study was censored after a maximal follow-up time of 2.5 years. The study was approved by the local ethics committees at Charité-Universitätsmedizin Berlin and the Technical University of Munich and was conducted in accordance with the Declaration of Helsinki in its currently applicable version and applicable German laws. All participants gave informed written consent. Fourteen Berlin patients and 12 Munich patients had been included in prior cross-sectional OCT studies. 23, 24 Exclusion criteria were ON in both eyes, fulfillment of the 2010 revised McDonald diagnostic criteria for MS 5 at study inclusion, a diagnosis of other neuroinflammatory disorders (ie, neuromyelitis optica spectrum disorders), 25 ,26 any ophthalmologic comorbidity or refractive error of more than 6 diopters, and a period of less than 30 days between initial event and study inclusion to avoid inclusion of disability scores obtained in the acute disease phase. Assessments at study inclusion comprised neurological examination including the Expanded Disability Status Scale (EDSS) score, brain MRI at3Tw i t hquantification of T2-weighted (T2w) lesions and gadolinium-enhancing lesions and retinal OCT. All examinations were completed within 2 weeks of study enrollment. Follow-up visits were performed at least yearly. In Berlin, follow-up visits were carried out in 12-month intervals from the initial event and included evaluation of relapses, EDSS scores, and MRI. In Munich, follow-up visits including MRI were carried out every 12 months, while evaluation of relapses and EDSS scores occurred more frequently (every 3-6 months, depending on patient presentation).
The primary outcome parameter was not meeting the no evidence of disease activity (NEDA-3) criteria, defined as freedom from relapses, absence of sustained disability worsening, and stable radiographic parameters (no change in T2w lesion load and absence of gadolinium-enhancing lesions on brain MRI). 27 Additional outcome was MS diagnosis according to the 2010 revision of McDonald criteria (McDonald MS).
5
Separate analyses of diagnosis were conducted for MRI measures indicated MS (eg, T2w lesion load, occurrence of gadolinium-enhancing lesions) (MRI-MS) or clinical definite
Key Points
Question Is optical coherence tomography associated with future disease activity in patients with clinically isolated syndrome?
Findings In this longitudinal cohort study of 97 patients with clinically isolated syndrome, ganglion cell and inner plexiform layer thickness in eyes without optic neuritis was associated with future disease activity. Patients with thickness in the thinnest tertile had a 3.3-times increased rate for not meeting the no evidence of disease activity-3 criteria compared with patients whose results were in the thickest tertile.
Meaning Optical coherence tomography might aid in future monitoring and treatment decisions in patients with clinically isolated syndrome.
MS (CDMS)
, defined by a second clinical relapse. Finally, disability worsening was analyzed as a further outcome parameter, defined as an increase in the EDSS score of 1.0 point or more or an increase of 1.5 points or more in patients with an EDSS score of 0 at study inclusion, confirmed by a visit at least 3 months later. Notably, a diagnosis of MRI-MS is synonymous with the development of new lesions in our cohort.
Magnetic Resonance Imaging
The MRI sequences are described in detail in the eMethods of the Supplement. The T2w lesion count was assessed by the lesion prediction algorithm (Berlin) or the lesion growth algorithm (Munich) as implemented in the Lesion Segmentation Tool toolbox, version 2.0.15 for Statistical Parametric Mapping software (Wellcome Trust Centre for Neuroimaging).
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Different lesion segmentation algorithms were used because each center chose the method delivering the best results for their scans based on expert visual inspection.
Optical Coherence Tomography
All participants underwent retinal OCT examination with assessment of the pRNFL and macular GCIP and INL. Details of OCT assessments are described in the eMethods in the Supplement. Seven macular scans of 7 patients and 3 peripapillary ring scans of 3 patients were excluded because of insufficient quality, and 1 eye was excluded because of severe myopia. Only non-ON eyes were included in the analyses (n = 161). A total of 90 healthy control participants were selected from the databases of both institutions (55 from Berlin and 35 from Munich) to provide reference values for OCT images.
Statistical Analysis
Results are presented as either mean (SD) or median with interquartile range (IQR). Characteristics at study inclusion were analyzed using Mann-Whitney U test and Pearson χ 2 . Differences in retinal layer thickness between patients with CIS and control participants were analyzed using generalized estimation equation models with the correlation matrix "exchangeable" to account for intereye and intrapatient dependencies.
To determine the risk of meeting the respective outcomes parameters associated with retinal thickness, Kaplan-Meier estimates and unadjusted Cox regression models were used. We chose tertile dividers for OCT parameters of non-ON eyes and compared risks associated with GCIP thickness values in the lowest or intermediate tertile vs the highest tertile. 21 If both eyes of a patient were non-ON eyes, the mean value of both eyes was used. The Kruskal-Wallis rank sum test was used for analyzing differences in time between initial event and study inclusion between the OCT tertile groups. Median follow-up time for censored data was calculated using reverse KaplanMeier estimates. 29 We then used a multiple Cox proportional hazard regression model including variables that had been identified as risk factors in other CIS cohorts. 11 In addition to GCIP, age (median divider), sex, ON as presenting syndrome, presence of 1 or more infratentorial lesion, T2w lesion count (tertile divider), and disease-modifying treatment were included as covariates. We tested the proportional hazards assumption for all variables of the unadjusted and multiple Cox regression models. The assumption was met for all variables; however, the status of disease-modifying treatment can change over time. Therefore, we included this variable as a timevarying covariate, with patients categorized as taking treatment at the time of the visit or not taking treatment at the time of the visit in the multiple Cox model. We report the hazard ratio (HR) with 95% CIs and the model's accuracy with Harrell C statistics. Statistical significance was established at P < .05. All analyses were performed in R, version 3.4.2 (R Foundation for Statistical Computing). Data analysis occurred from May to July 2017.
Results
Characteristics at Study Inclusion
Within both centers, 179 patients with CIS were screened for eligibility for the current study (eMethods in the Supplement). Ninety-seven patients with CIS (45 in Berlin and 52 in Munich) met all inclusion criteria and were included ( presenting clinical symptom. The GCIP and pRNFL thickness measurements of eyes without ON in patients with CIS were in the range of the matched healthy control participants, while the INL was slightly thicker ( Table 2) .
To assess the value of each OCT parameter at inclusion as a potential risk factor for meeting the respective outcome parameters, we grouped patients into tertiles according to the thickness of GCIP, pRNFL, or INL thicknesses of non-ON eyes at the time of study enrollment (Table 2) .
To allow a comparison of our cohort with other cohorts of patients with CIS, we report a comparison of baseline characteristics and events at follow-up in our cohort with 3 independent cohorts from earlier publications 11, 12, 30 
Center Differences
There were significant differences in patient characteristics at study inclusion between the centers regarding the time between initial event and study inclusion 
Follow-up
Of 97 patients with CIS, 58 (60%) exhibited disease activity during follow-up, defined as not meeting NEDA-3 criteria. Furthermore, 53 (55%) were diagnosed with McDonald MS; of those, 36 (37%) fulfilled MRI-MS criteria, and 24 (24%) fulfilled CDMS criteria by experiencing a relapse. Eleven patients (11%) exhibited sustained worsening of EDSS score. The 3 patients who did not meet NEDA-3 criteria but did not fulfill diagnostic criteria for MS had experienced EDSS score worsening within the functional system. The median (IQR) duration of clinical follow-up (in Kaplan-Meier analysis, NEDA-3 survival time) was 729 days (664-903) days (censoring occurred either when NEDA-3 status was not met or the end of the clinical follow-up period, whichever came first). There were no differences in follow-up time between both centers. Also, time between initial event and study inclusion prior to OCT examination and follow-up duration between the OCT parameter tertile groups were not different for all retinal layers. Five patients from both centers declined further participation in the study after at least 2 years of follow-up (eMethods in the Supplement).
Factors Associated With Disease Activity, MS Diagnosis, and Disability Worsening Figure 2B ). 
Research Original Investigation Retinal Ganglion Cell Layer and Disease Activity in Clinically Isolated Syndrome
Rates for diagnosis of CDMS and EDSS score worsening were not significantly different between the GCIP tertile groups ( Figure 2C and D) . Notably, these analyses were of limited feasibility because of the low number of events.
We then fit a multiple Cox proportional hazard model to further investigate the association of GCIP thickness and other parameters with not meeting NEDA-3 (Figure 3) . Only complete data sets were included in the Cox model (n = 89). Unadjusted analysis for each parameters are reported in eTable 4 and eFigure in the Supplement. The distribution of the GCIP tertiles remained the same for the 89 patients with complete data sets. Compared with patients with GCIP thickness in the highest tertile at study enrollment, patients in the intermediate tertile had a statistically nonsignificant trend toward an increased rate of not meeting NEDA-3 (HR, 1.84; 95% CI, 0.85-3.97; P = .12). Patients with a GCIP thickness at inclusion in the lowest tertile had 3.43-fold higher rate of not meeting NEDA-3 criteria compared with the group with the highest GCIP thickness (HR, 3.43; 95% CI, 1.63-7.18; P = .001).
The rate of not meeting NEDA-3 criteria was neither influenced by sex nor age. Patients with ON as their initial symptom had a nonsignificantly lower rate (HR, 0.59; 95% CI, 0.32-1.11; P = .10) of this outcome compared with patients with clinical manifestations in other functional systems. Notably, the presence of at least 1 infratentorial lesion and the number of T2w lesions did not change the rate of not meeting NEDA-3 criteria (Figure 3 To exclude potential confounders, the same models were additionally computed with the covariates time between initial event and study inclusion and center. Neither was significantly associated with not meeting NEDA-3 criteria, nor did including these variables change the results for the association of GCIP with not meeting NEDA-3. Separate analyses (unadjusted models) for both centers showed comparable results (eTable 5 in the Supplement). Oligoclonal bands were not included in the multiple Cox model since oligoclonal bands were absent in only 9 patients; of those, 4 did not meet the NEDA-3 criteria.
Discussion
Retinal GCIP thickness measured by OCT within 12 months after the first clinical event in eyes without former ON is a prognostic factor for subsequent disease activity in patients with CIS. Values of GCIP thickness less than 69.2 μm were a risk factor for not meeting NEDA-3 criteria (at more than a 3-fold increased rate) and a subsequent diagnosis of MS. Conversely, higher GCIP thickness was associated with a higher probability of remaining free from disease activity and of retaining CIS status.
Loss of retinal ganglion cells indicated by GCIP thinning on OCT scan is a frequent finding in patients with MS. The Statistics from log-rank test of ganglion cell and inner plexiform layer grouping (A), peripapillary retinal nerve fiber layer thickness grouping (B), and inner nuclear layer grouping (C). Shaded regions describe the 95% CIs.
Retinal As with low GCIP, low pRNFL thickness was associated with an increased rate of subsequent disease activity defined as not meeting the NEDA-3 criteria. A large retrospective multicenter study of 879 patients showed that low pRNFL is a risk factor for sustained EDSS score worsening during a 5-year follow-up period. 21 This study also included a subgroup with CIS (n = 74), in which no such association was observed, presumably owing to the low sample size of patients with a sufficiently long duration of observation. Likewise, our data preclude meaningful conclusions with regards to a possible association of OCT measurements with disability worsening, given that we observed only a few events of EDSS score worsening, and owing to the recent observation that short-term I   II   II II I  II I I  IIII III I   II  I II II I  II I I I III I I I II  II   II I  I I I   I I I I I   I   II II II I  II I  IIII I   II I  I II   II I I II II I  I  II I I III I I I I I II  I  I  I II II  I  I I II D, Disability worsening defined as sustained Ն1 point worsening in Expanded Disability Status Scale (EDSS) score (or Ն1.5 point score-worsening in patients with EDSS of 0 at study inclusion). Shaded regions describe the 95% CIs.
Research Original Investigation
Retinal Ganglion Cell Layer and Disease Activity in Clinically Isolated Syndrome follow up assessments may overestimate progression rates. 38 Thus, our study confirms in an independent cohort that retinal layer thicknesses do not suggest subsequent EDSS score worsening in patients with CIS. It remains elusive whether this is because both studies were underpowered or whether OCT is just not useful to assess the future possibility of disability worsening in CIS. The INL thickness has been connected to inflammatory patterns of MS disease activity. Thicker INL and microcystic INL edema are associated with increased paraclinical tissue inflammation in MRI and higher relapse rates.
24,39-41 The thickening of INL correlates with larger white matter lesion volumes, and sufficient immunotherapy has been shown to reduce INL volumes in patients with MS. 22 In contrast to GCIP and pRNFL thickness, INL measures in our study were different from controls at inclusion but had no association with disease activity. One possible explanation might be that changes to INL induced by diseasemodifying therapy confound analysis.
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In our study, not meeting NEDA-3 criteria was largely synonymous with fulfilling the diagnostic criteria of MS according to the 2010 revision of the McDonald criteria.
5 Only 3 patients did not meet NEDA-3 but were not diagnosed with MS. In each case, not meeting NEDA-3 was caused by disability worsening, in form of a sustained EDSS score increase but without dissemination of lesions over time. Several other risk factors for MS conversion and disease activity in patients with CIS have been previously described. A large prospective cohort study on 1015 patients with CIS and a mean follow-up duration of 81 months identified the presence of oligoclonal bands in the cerebrospinal fluid and high lesion counts in cerebral MRI as strong risk factors for progression into CDMS.
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In this study, we did not find an association of T2w lesion counts or presence of infratentorial lesions with subsequent disease activity. This is surprising, given the strong associative power of T2w lesions in previous studies.
11,12 The difference presumably stems from cohort differences. Both centers in our study are tertiary referral centers, and our sample included mostly patients in whom the primary neurologist had already determined a potential risk of MS. For example, in the study by Tintore et al, 11 31.4% of all patients with CIS had no T2w lesions, whereas this was only the case for 10.1% of the patients in our study. Furthermore, we accepted an interval of as long as 365 days between CIS onset and study enrollment, which was long compared with other studies. 11, 12 This might have created a potential selection bias toward more benign patients with risk of MS, since patients at higher risk may have already converted to MS during that period. However, despite significant center differences between the patients from Munich and Berlin at study inclusion, these differences had no impact on the associative power of GCIP or pRNFL, which further supports the generalizability of our results. Another explanation could be that the number of variables in the multiple Cox regression may have overstressed the model in light of the limited sample size and number of events. However, a multivariate approach is required to confirm the effect of retinal layer thicknesses and determine their weight in meeting the outcomes. This is why we maintained the multiple Cox model but performed all analyses additionally in an unadjusted manner and reported these in eTables 4 and 5 in the Supplement.
Limitations
An important disadvantage of OCT is that measurements are not easily comparable between devices. While pRNFL analysis has a high level of standardization and reference values are available in many OCT devices, macular intraretinal layer analysis lacks this standardization, 42 and we therefore included a reference data set of measurements from healthy control participants. Despite their power, GCIP and pRNFL in patients were comparable with the control participants, whereas INL was mildly increased. Thus, the underlying mechanism behind the association of GCIP and pRNFL with progression to MS remains elusive. In line with our findings, some previous studies reported no evidence of pRNFL reduction in non-ON eyes in patients with CIS when compared with healthy control participants. 43, 44 Conversely, other studies found pRNFL loss compared with healthy control participants 45 or reported a subtle GCIP reduction in patients with CIS or early MS mostly in the form of a focal thickness reduction. 23 Moreover, advanced OCT technology might thus be able to unveil subtle changes missed by quantitation of GCIP and pRNFL, where acquisition protocols determine a mean thickness over their respective measurement regions. The GCIP differences between the tertiles .18
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Hazard Ratio (95% CI) were sufficiently large in comparison with the coefficient of repeatability of less than 1 μm, 42 which supports the potential clinical utility of GCIP measurements in the suggested context. These limitations limit the generalizability of our study. It is important to acknowledge that associations on a group level do not necessarily translate into an individual prognosis for a single patient. Ultimately, population-based studies with clear clinically derived inclusion criteria are needed to transform associations on a group level into an individual assessment measure.
Conclusions
In summary, we identified GCIP thickness and to a lesser extent pRNFL as retinal imaging biomarkers for subsequent disease activity in patients with CIS. When obtained routinely during initial workup for suspected central nervous system-demyelinating disease, they can inform early appraisal of future disease activity in patients with CIS. In clinical research, they can support risk-adjusted patient stratification. In clinical care, they can potentially help identifying patients with CIS with worse prognoses and might thus support a risk-adjusted treatment initiation. In Berlin and Munich, both cohort studies "Berlin CIS cohort" and "TUM-MS cohort" on patients with CIS and early MS were conducted independently of clinical routine; patients were proactively enlisted for the study after being informed by their treating physician or from advertisements. Thus, there are no records on patients who declined to participate.
In Berlin, among 109 screened patients at time of data closing for this project, only the patients with CIS who did not fulfill 2010 diagnostic criteria for MS at time of study inclusion were selected (n=80). Then 2 patients had to be excluded because of a period longer than 365 days between CIS onset and study inclusion, and 28 because of insufficient follow-up. Among them, 14 declined further participation, and 10 had not yet reached their necessary follow-up visit. From the remaining 50 CIS patients, 1 patient was excluded because of bilateral ON, three patients due to myopia in both eyes, and 1 patient because of technical problems. Thus, a total of 45 patients from Berlin met all criteria and were enrolled into the analysis.
In Munich, 578 patients from TUM-MS study with available OCT-data were screened at the time of data closing for this project. Here, 479 patients fulfilled 2010 diagnostic criteria for MS; among the remaining 99 CIS patients, 46 patients had a period longer than 365 days between CIS onset and study inclusion and 1 patient suffered from bilateral ON. Thus, a total of 52 patients from Munich met all criteria and were enrolled into the study.
Both cohorts are from ongoing, longitudinal studies investigating CIS patients. The studies are still ongoing, and the different observation times result from different times of inclusion in the respective studies. Five patients declined further participation in the study after 2 years (2 from Berlin, 1 from Munich) or 3 years (2 from Berlin). Besides this, no lost-to-follow-ups have been recorded in Berlin and Munich.
MRI sequences
In Berlin, 3D whole brain MR data (1mm 3 ) were acquired on a 3 Tesla whole-body MRI (Magnetom Trio with TIM, Siemens Healthcare AG, Germany), using a 12-channel head coil. For T2w imaging a single slab 3D T2w turbo-spin-echo (TSE) sequence with high sampling efficiency (SPACE) was selected (TE: 388 ms; TR: 6000 ms; flip angle: 120°) as well as a 3D fluid attenuated inversion recovery sequence (SPACE-FLAIR; TE: 502 ms, TR: 5000 ms; TI: 2100 ms; flip angle: 120°), followed by an axial 2D double-echo proton density/T2w sequence (TE: 14/87 ms, TR: 3400 ms, flip angle: 120°, voxel resolution: 1 x 1 x 3 mm 3 , no gap). Contrast enhanced images were acquired using a volumetric high-resolution T1 weighted magnetization prepared rapid acquisition gradient echo (MPRAGE) sequence (MPRAGE: 1mm 3 ; TE: 2.55 ms; TR: 1900 ms; flip angle: 9°). In Munich, brain images were acquired on a 3 Tesla scanner (Achieva, Philips, Netherlands), using a 16-channel head coil. The scanning protocol included a 3D FLAIR sequence (TE: 140 ms, TR: 10000 ms, TI: 2750 ms, 144 contiguous axial 1.5 mm slices; field of view: 230 × 185 mm²; voxel size: 1.0 × 1.0 × 1.5 mm³). Contrast enhanced images were acquired using a volumetric 3D GRE T1-weighted sequence (TE: 4 ms, TR 9 ms, flip angle 8°; 170 contiguous sagittal 1-mm slices; field of view: 240 × 240 mm²; voxel size: 1.0 × 1.0 × 1.0 mm
Optical coherence tomography
All subjects underwent retinal examination using a Spectralis spectral domain OCT (Heidelberg Engineering, Heidelberg, Germany) at inclusion without pupil dilation at room light. Experienced operators performed OCT using a single device in each study center. A macular volume scan (25°x30°, 61 vertical B-scans, high-speed mode, automatic real time (ART) 12-15) was recorded, and the GCIP and INL were assessed within a 6 mm diameter cylinder around the fovea. A peripapillary 3.4 mm ring scan centered on the optic nerve head (ART 16-100) was recorded for pRNFL. Retinal layer segmentation was calculated automatically with Heidelberg Eye Explorer Version 6.0.9.0. Automatic segmentation results were supervised by two experienced graders in each center and were manually corrected if necessary. All examinations were checked for sufficient quality. 
